Inflexion is to acquire Sunovion Pharmaceuticals Europe (SPE) from US-based Sunovion Pharmaceuticals, according to a statement from parent company Sumitomo Dainippon Pharma.
Inflexion is to acquire Sunovion Pharmaceuticals Europe (SPE) from US-based Sunovion Pharmaceuticals, according to a statement from parent company Sumitomo Dainippon Pharma.